Snipr Biome fights to regain five US patents

The Rockefeller University in New York claims to have originated one of Snipr Biome’s technologies, an argument that led to the biotech firm losing five patents after a ruling last year. Now, the firm wants them back.

Five of patents in the US are in the balance as The Rockefeller University and Snipr Biome hash it out: Who can claim ownership, the first to invent or file? | Photo: LUKAS BARTH/REUTERS / X03379

Snipr Biome is involved in a patent lawsuit in the US, where the firm and The Rockefeller University are clashing over who owns certain technology patents, Danish media Børsen reports.

The US Patent and Trademark Office (USPTO) sided with the university back in December 2021, crediting Rockefeller with the invention of bacteria-killing CRISPR technology and cancelling five of SNIPR’s 21 patents in the US.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs